Recruiting
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
Major Depressive Disorder
A Phase 3 Double-blind, Placebo-controlled Study (Part A) with an Open-label Extension (Part B) Evaluating DT120 Compared to Placebo in Major Depressive Disorder - Ascend
Bennington, VT18–74 yrsAll genders
See details & check eligibility